Non-steroidal treatment of pollen-induced conjunctivitis: Comparison of different pharmacological protocols

G. Ciprandi, P. M. Cerqueti, S. Sacca, G. Ciurlo, M. A. Tosca, G. W. Canonica

Research output: Contribution to journalArticlepeer-review


Pharmacological treatment of allergic conjunctivitis may be based on the therapeutic use of topical steroids; however, because of the side effects, steroids are not clinically suitable in either prolonged treatment, or pollinosis. Because non-steroidal topical drugs are suitable in prolonged treatment, this single-blind study evaluated the following topical drugs: cromoglycate plus chlorphenamine, cromoglycate plus tetryzolin and imidazolin plus nafazolin, compared with placebo. The results confirm significant clinical efficacy of these drugs on signs and symptoms compared with placebo. Thus, 'non-steroidal' topical drugs should be the preferred choice in prolonged forms of pollen-induced (e.g. Parietaria and/or grasses) conjunctivitis.

Original languageEnglish
Pages (from-to)393-395
Number of pages3
JournalAllergy: European Journal of Allergy and Clinical Immunology
Issue number5
Publication statusPublished - 1991


  • antihistamines
  • cromoglycate
  • imidazoline derivatives
  • non-steroidal topical drugs
  • pollen-induced conjunctivitis

ASJC Scopus subject areas

  • Immunology


Dive into the research topics of 'Non-steroidal treatment of pollen-induced conjunctivitis: Comparison of different pharmacological protocols'. Together they form a unique fingerprint.

Cite this